Aspirin for primary prevention of CV events: yes or no?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Continuation or interruption of OAC during TAVI?
Dirk Jan van Ginkel, MD
Jeff Healey, MD
- ESC Congress 2023Outcomes of two DAPT trials in patients undergoing PCI
Freek Verheugt, MD
- ESC Congress 2023Unexpected results after switching from VKA to DOAC in frail older patients with AF
Linda Joosten, MD